Author: BusinessWire

Alzheon CEO Dr. Martin Tolar Will Provide Overview of Company Business and Update on Oral Anti-Amyloid ALZ-801 Phase 3 Program
FRAMINGHAM, Mass.–(BUSINESS WIRE)–#ALZ801–Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing…

BOULDER, Colo.–(BUSINESS WIRE)–#BDSX–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the fourth quarter and year ended Decembe…

Jurascheck, a senior Engineering executive, brings over twenty years of experience to the role
LONDON–(BUSINESS WIRE)–#Automation–Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rat…

GEORGETOWN, Texas–(BUSINESS WIRE)–Austhera BioSciences, Inc. today announced that Edward Rudnic, CEO and David Snyder, CFO will present an overview of the company at the upcoming 2021 Spring Private Company Showcase hosted by Credit Suisse, Solebury …

GEORGETOWN, Texas–(BUSINESS WIRE)–Austhera BioSciences, Inc. today announced that Edward Rudnic, CEO and David Snyder, CFO will present an overview of the company at the upcoming 2021 Spring Private Company Showcase hosted by Credit Suisse, Solebury …

GEORGETOWN, Texas–(BUSINESS WIRE)–Austhera BioSciences, Inc. today announced that Edward Rudnic, CEO and David Snyder, CFO will present an overview of the company at the upcoming 2021 Spring Private Company Showcase hosted by Credit Suisse, Solebury …

GEORGETOWN, Texas–(BUSINESS WIRE)–Austhera BioSciences, Inc. today announced that Edward Rudnic, CEO and David Snyder, CFO will present an overview of the company at the upcoming 2021 Spring Private Company Showcase hosted by Credit Suisse, Solebury …

EL SEGUNDO, Calif.–(BUSINESS WIRE)–NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the pending merger…

EL SEGUNDO, Calif.–(BUSINESS WIRE)–NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the pending merger…

LONDON–(BUSINESS WIRE)–ALSA Ventures today announced the launch of Promatix Inc., a Delaware incorporated company, to develop novel therapeutics with the potential to transform the treatment of cancer. Promatix will use its multi-omic proprietary dat…